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Phospholipid vesicleIn a previous study, it was shown that puriﬁed preS domains of hepatitis B virus (HBV) could interact with acidic
phospholipid vesicles and induce aggregation, lipidmixing and leakage of internal contentswhich could be indic-
ative of their involvement in the fusion of the viral and cellular membranes (Núñez, E. et al. 2009. Interaction of
preS domains of hepatitis B viruswith phospholipid vesicles. Biochim. Biophys. Acta 17884:417–424). In order to
locate the region responsible for the fusogenic properties of preS, ﬁve mutant proteins have been obtained from
the preS1 domain of HBV, in which 40 amino acids have been deleted from the sequence, with the starting point
of each deletionmoving 20 residues along the sequence. These proteins have been characterized by ﬂuorescence
and circular dichroism spectroscopy, establishing that, in all cases, they retain their mostly non-ordered confor-
mation with a high percentage of β structure typical of the full-length protein. All themutants can insert into the
lipid matrix of dimyristoylphosphatidylglycerol vesicles. Moreover, we have studied the interaction of the pro-
teins with acidic phospholipid vesicles and each one produces, to a greater or lesser extent, the effects of
destabilizing vesicles observedwith the full-length preS domain. The ability of all mutants, which cover the com-
plete sequence of preS1, to destabilize the phospholipid bilayers points to a three-dimensional structure and/or
distribution of amino acids rather than to a particular amino acid sequence as being responsible for the mem-
brane fusion process.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Hepatitis B virus (HBV) is a small DNA virus which infects the liver.
Although infection is usually followed by a complete recovery, in
some cases the infection becomes chronic and may result in the devel-
opment of cirrhosis and hepatocellular carcinoma. HBV infection is
still a worldwide health problem despite the fact that an effective
vaccine has been available for more than 25 years. About 240 million
people are chronic carriers of HBV and about 1 million become infected
yearly [1].itro-2,1,3-benzoxadiazol-4-yl)-





l, 06300 Zafra, Badajoz, Spain.
e Estrellas, 5-7, 28042 Madrid,HBV envelope proteins are involved in the binding of the virus to the
hepatocytes and in the cell entrymechanism [2]. There are three surface
proteins designated as the small (S),medium (M) and large (L), that are
the product of a single open reading frame. They share 226 amino acids
(full-length S protein) at the C-terminus. The M protein has an
extension of 55 amino acids, preS2, at the N-terminus of the S. The L
protein is composed of the entire M protein and the preS1 region at
the N-terminus which has 108–119 amino acids, depending on the
HBV genotype. The regions preS1 and preS2 together are known as
preS domains [3].
The preS domains are functional at different steps of the virus life
cycle. Several studies have demonstrated that preS1, and not preS2,
contains the main hepatocyte speciﬁc binding domain [4], speciﬁcally
a region from 21 to 47 residues [5–9]. Other studies indicate that the
full-length preS1 domain, with the exception of amino acids 78 to 87,
is essential for the infectivity of HBV [10] and the species speciﬁcity
has been attributed to the ﬁrst 30 amino acids of preS1 (subtype ayw)
[11]. It is also widely accepted that myristoylation at Gly2 residue of
the preS1 domain plays an important role in speciﬁc binding to hepato-
cytes [3,12–14]. Several molecules have been proposed to play a role in
binding of HBV to hepatocytes [3,15–17]. Very recently sodium
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cellular receptor [18].
Little is known about the involvement of the envelope proteins in the
fusion between the viral and the host cellmembrane. A peptide compris-
ing the 16 amino acids at the N-terminal end of S protein have been
shown to interact with model membranes, causing liposome
destabilization in a pH-dependent manner and adopting an extended
conformation during the process [19,20]. Evidence for the role of the
N-terminal S peptide in woodchuck hepatitis B virus (WHV) or duck
hepatitis B virus (DHBV) infectivity has also been obtained by others
researchers [21,22]. On the other hand, we have previously shown that
isolated preS domains (subtypes adw and ayw) are able to interact
with acidic phospholipids vesicles and, as a result of this interaction,
cause the destabilization of the bilayer, both at neutral and acidic pH
[23]. Furthermore, the addition of this type of phospholipid vesicles led
to a conformational change in the preS domain, increasing its helical con-
tent [23]. Similar results were obtained with the DHBV preS domain, de-
spite the difference in the amino acid sequence [24]. Both domains share
a similar hydrophobic proﬁle, indicating that a three-dimensional con-
formation rather than a particular amino acid sequence would be re-
sponsible for the properties observed [24]. These results point to the
possibility that both S and preS regions could contribute to the fusion
of the viral and cellular membranes. Moreover, it has been shown that
the preS2 domain plays an important role in virus assembly but it is dis-
pensable in virus entry [25].
With the aim to locate the region of the preS domains responsible for
the fusogenic properties, ﬁve deletion mutants along the preS1
sequence (subtype ayw) have been prepared. In each mutant,
40 amino acids were deleted, with the starting point of each deletion
moving 20 residues along the sequence. Thus, themutants are designated
preSΔ1–40, preSΔ20–60, preSΔ40–80, preSΔ60–100 and preSΔ80–120, indicating
the deleted region in each case. All the proteins were characterized
spectroscopically, and their interaction with phospholipids was studied.
2. Materials and methods
2.1. Enzymes and reagents
Restriction enzymes, ligases, DNApolymerase andothermolecular bi-
ology reagents were obtained from New England Biolabs, Promega,
Invitrogen, Novagen or BRL. N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-
dimyristoylphosphatidylethanolamine (NBD-PE), N-(lissamine rhoda-
mine B sulfonyl)-diacylphosphatidylethanolamine (Rh-PE) and
dimyristoylphosphatidylglycerol (DMPG) were provided by Avanti
Polar Lipids. 8-Aminonaphtalene-1,3,6-trisulfonic acid (ANTS),
p-xylenebis(pyridinium) bromide (DPX) and 4-ﬂuoro-7-nitrobenz-2-
oxa-1,3-diazole (NBD-F) were purchased from Molecular Probes. Triton
X-100 was obtained from Boehringer Mannheim. Sepharose CL-6B
Ni-nitrilotriacetic acid (NTA) was purchased from Qiagen. All other
reagents were obtained from Merck and Sigma. All solvents were of
HPLC grade.
2.2. Cloning of preS-his and preSΔ1–40
To clone the preS domain (subtype ayw) and the preSΔ1–40 deletion
mutant in the plasmid pT7-7 (Gibco BRL), the plasmid pET3d-preS-his-
ayw [26], which contains the full-length preS domain (subtype ayw)
followed by a region encoding a six-histidines tag at the carboxy-
terminal end, was used as template. The forward primers used were
preS-NdeI(+): 5-′GGA GAT ATA CAT ATG GGG CAG AAT C and Δ1-40-
NdeI(+): 5′C AAC AAG CAT ATG TGG CCA GAC GC; the reverse primer
for both cloning was preS-HindIII(-): 5′-GCA GCC AAG CTT CTA CTA
ATG GTG. Underlined are the NdeI and HindIII restriction sites included
in the primers.
The PCR reaction conditions were: 1 min at 94 °C, followed by ﬁve
cycles at 94, 60 and 72 °C, each for 1 min, by 30 cycles at 94, 55 and72 °C, each for 1 min, and a ﬁnal “ﬁlling in” step at 72 °C for 7 min.
The fragment of ampliﬁedDNAwas puriﬁed byWizard PCR Prep system
(Promega) and was subcloned into the linear plasmid pCR2.1
(Invitrogen), with 3′T ends and ampicillin resistance gene. pCR2.1-
preS and pT7-7 plasmids were subsequently digested with restriction
enzymes NdeI (Boehringer Mannheim, 10 U/μL) and HindIII (New En-
gland Biolabs, 20 U/μL), in a ﬁnal volume of 10 μL at room temperature
for 16 h. After digestion, a 1% agarose gelwas run. Once the suitable frag-
ments had been copuriﬁed, using the QIAEX system (QIAGEN), they
were ligated with bacteriophage T4 DNA ligase (Gibco BRL, 1 U/μL), at
room temperature for 1-2 h, and Escherichia coli DH5αF′ cells were
transformed with half of the reaction mixture. The positive colonies
were identiﬁed by digestion of puriﬁed plasmidDNAwith the restriction
enzymes NdeI and HindIII. The individual cDNA sequences were
conﬁrmed by automated DNA sequencing. The resulting recombinant
plasmids were called pT7-7-preS and pT7-7-Δ1-40.
2.3. Cloning of preSΔ20–60, preSΔ40–80, preSΔ60–100 and preSΔ80–120
The rest of the mutant cDNAs were obtained by the method de-
scribed by Pogulis [27]. Brieﬂy, the regions on both sides of the deletion
were ampliﬁed separately by PCR, using the plasmid pT7-7-preS as tem-
plate. Internal primers of each mutant had a complementary region of
18 nucleotides, corresponding to the 9 ﬁnal nucleotides and the ﬁrst 9
nucleotides located before and after the deletion. The conditions of
this ﬁrst PCR reaction were the same as described above for preS and
preSΔ1–40. After running the PCR product on a 1.75% agarose gel and
copurifying both regions using the QIAEX system (QIAGEN), a second
elongation PCR using Taq Gold polymerase was carried out without
primers in order to expand the area. The PCR conditionswere: 15 cycles
at 94, 52 and 72 °C, each for 1 min, followed by 7 min at 72 °C.
Finally, a third PCR using the ampliﬁed sequences as template, and
the oligonucleotides preS-NdeI(+) and preS-HindIII(-) as primers, re-
sulted in a DNA fragment with a region of 120 nucleotides deleted and
3′A ends. The PCR conditions were: 32 cycles at 94, 55 and 72 °C, each
for 1 min, followed by a ﬁnal step of 7 min at 72 °C. Then, they were
cloned into the pCR2.1 plasmid, digested with restriction enzymes
NdeI and HindIII and subsequently cloned into the plasmid pT7-7
digested with the same enzymes. The sequences of the different genes
were conﬁrmed by automated DNA sequencing.
2.4. Expression and puriﬁcation of preS-his and deletion mutants
pT7-7 recombinant plasmids with the preS-his domain or the
different deletion mutants were used to transform E. coli HMS174 (DE3)
cells. In all cases, the expression of the recombinant protein was
under the control of the T-7 promoter, inducible by isopropyl-D-
thiogalactopiranosyde (IPTG).
A single colony was used to inoculate 50 mL of M9 medium
supplemented with 0.17% glucose, 1.06 mM MgSO4, 0.053 mM CaCl2
and 100 μg/mL ampicillin. Following overnight incubation at 37 °C,
the culture was used to inoculate 950mL of the samemedium. This cul-
ture was grown to an optical density at 600 nm of 0.6 and the IPTGwas
added to a ﬁnal concentration of 0.5 mM, and incubated at 37 °C for 4 h
to induce protein expression. Cells were harvested by centrifugation at
7400 g for 10 min in a GS-3 rotor (Sorvall). The cell pellet was resus-
pended in ice cold 10 mM MOPS pH 8.0, 10 mM imidazole, 0.3 M
NaCl, 6 M Urea to avoid proteolytic degradation of proteins. Cells were
lysed by sonication and centrifuged at 89500 g for 30min in a Beckman
SW-28 rotor.
Recombinant proteins were puriﬁed using a single afﬁnity chroma-
tography step in Sepharose CL-6B Ni-nitrilotriacetic acid (NTA)-agarose
column (Qiagen) equilibrated with 10 mMMOPS pH 8.0, 10 mM imid-
azole, 0.3 M NaCl, 6 M Urea. After washing the non-speciﬁcally bound
proteinswith 10mMMOPS pH 8.0, 30mM imidazole, 6 MUrea, elution
of the proteins was performed with 10 mM MOPS pH 8.0, 200 mM
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MOPS pH 7.0. The presence of the different proteins was monitored
through the puriﬁcation by SDS-PAGE. The amino acid composition
and the protein concentration were determined on a Beckman 6300
automatic amino acid analyzer.
2.5. Spectroscopic characterization of preS-his proteins
The far-UV circular dichroism spectrawere recorded on a Jasco J-715
spectropolarimeter equippedwith a thermostated cell. The protein con-
centration was 0.1mg/mL. The buffer used was 10mMMOPS, pH 7.0 or
pH 5.0. A minimum of three spectra were accumulated for each sample
and the contribution of the buffer was subtracted. Values of mean resi-
due ellipticity were calculated on the basis of 110 as the averagemolec-
ular mass per residue and they are reported in terms of [θ]M.R.W.
(degrees × cm2 × dmol−1). The secondary structure of each protein
was evaluated by computer ﬁt of the dichroism spectra according to
the algorithm convex constraint analysis (CCA) [28]. This method relies
on an algorithm that calculates the contribution of the secondary
structure elements that give rise to the original spectral curve without
referring to spectra from model systems.
Fluorescence studies were performed on a SLM Aminco 8000C spec-
troﬂuorimeter ﬁtted with a 450 W Xenon lamp. The slits were set at
4 nm and the integration time was 1 s. The protein concentration was
always 0.05 mg/mL. The buffer used was 10 mm MOPS, pH 5.0 or 7.0.
At least three spectra were accumulated and the contribution of the
buffer was subtracted. Excitation was performed at a wavelength of
275 or 295 nm, and emission spectra measured over a range of 285–
465 nm. The tyrosine contribution to the emission spectra was calculat-
ed by subtracting from the emission spectrameasured atλexc=275 nm
the emission spectra measured at λexc = 295 nmmultiplied by a factor
that was obtained from the ratio between the ﬂuorescence intensities
measured with λexc = 275 nm and λexc = 295 nm at wavelengths
higher than 380 nm, where there is no tyrosine contribution.
2.6. Labeling of preS-his proteins
Fluorescent labeling of the N-terminus of the protein was achieved
by the procedure of Rapaport and Shai [29] as previously described
[24]. Some NBD-labeled proteins precipitated in the column. In these
cases, the protein was denatured with 6 M Urea. The denaturant and
the excess label reagent were removed by exhaustive dialysis against
10 mM MOPS pH 5.0 or 7.0, with decreasing concentrations (1, 0.5,
0.2, 0.1 and 0 M) of Urea.
2.7. Vesicle preparation
The vesicles used were prepared by sonication and extrusion in a
Liposo Fast-Basic extruder apparatus (Avestin, Inc.) with 100-nm poly-
carbonate ﬁlters (Costar) as previously described [24].
2.8. Binding assay
The binding of NBD-preS-his or NBD-mutant proteins to PG vesicles
was studied as previously described [24]. Brieﬂy, after incubation of the
protein (0.03–0.06 μM) with the vesicles for 1–2 min, the ﬂuorescence
spectra were taken between 480 and 650 nm with the excitation
wavelength set at 467 nm in a SLM AMINCO 8000C spectroﬂuorimeter
(SLM Instruments). The ﬂuorescence intensity registered at 530 nm at
different lipid/protein molar ratios was utilized to obtain the binding
isotherm. The data were analyzed using the equation:
Xb
 ¼ Kp  Cf
where Xb⁎ is the molar ratio of bound protein per total lipid corrected
taking into account that proteins only partitioned over the outer leaﬂetof vesicles (Xb⁎=Xb / 0.6), Kp⁎ corresponds to the corrected partition co-
efﬁcient and Cf represents the equilibrium concentration of free protein
in solution. At every phospholipid concentration, the fraction of bound
protein can be calculated by the formula:
fb ¼ F−F0ð Þ= F∞ − F0ð Þ
where F0 represents the ﬂuorescence of unbound protein and F∞ the
ﬂuorescence of bound protein. In all cases, ﬂuorescence from control
vesicles in the absence of labeled protein was subtracted. At least
three different experiments were performed for each condition.
2.9. Vesicle aggregation
The aggregation of phospholipid vesicles induced by the addition of
preS-his and mutant proteins was followed by measuring the optical
density at 360 nm (ΔOD360) on a Beckman DU-7 spectrophotometer
[24]. The ﬁnal phospholipid concentration was kept at 60 μM. At least
three different experiments were performed for each condition.
2.10. Lipid mixing
The ﬂuorescent probe dilution assay [30] was employed to
determine lipid mixing. All the conditions are coincident with those
previously used for human and duck preS proteins [23]. The energy
transfer efﬁciency was calculated from the ratio of the emission intensi-
ties at 530 and 590 nm and the appropriated calibration curve.
2.11. Release of aqueous contents
The integrity of the phospholipid vesicles was assessed by the
ANTS/DPX leakage assay [31] as previously described [23]. ANTS
and DPX were co-encapsulated in phospholipid vesicles at 12.5 mM
and 45 mM respectively, in 10 mM Tris pH 7.2, 20 mM NaCl. The
non-encapsulated material was eliminated by chromatography in a
Sephadex G-75 column (Pharmacia). The phospholipid concentra-
tion was kept at 0.1–0.14 mM. The ﬂuorescence spectra were mea-
sured in a SLM Aminco 8000C spectroﬂuorimeter. The excitation
wavelength was set at 385 nm and the ANTS emission was moni-
tored at 520 nm. The ﬂuorescence of control vesicles without protein
was taken as 0% leakage while 100% was considered upon addition of
0.5% Triton X-100.
3. Results
3.1. Expression and puriﬁcation
After inducing the expression of the preS andmutantswith IPTG, the
recombinant proteins were puriﬁed as described in the Materials and
methods section. The results of the puriﬁcation steps of preS-his are
shown in Fig. 1A as an example. Induction with IPTG resulted in the ap-
pearance of a band which corresponded to the molecular mass of the
preS-his domain (Fig. 1A, lanes 2 and 3). After lysis of the cells all the
protein remained soluble (Fig. 1A, lane 5). Moreover, when loaded
onto the Ni-NTA column most of the protein was retained (Fig. 1A,
lane 6). The proteins were eluted with 10 mM MOPS pH 8.0, 200 mM
imidazole, 0.3 M NaCl, 6 M urea. All proteins were homogeneous as it
is shown by SDS-PAGE (Fig. 1B), with an electrophoretic mobility corre-
sponding to that expected according to their molecular mass (Table 1),
except for preS Δ40–80, which has a lower mobility (Fig. 1B, lane 5).
Moreover, their purity was higher than 98% in every case. Under
these conditions, 15 mg per liter of cell culture of preS-his and about
3–6 mg of the different mutants were obtained.
The amino acid composition of the puriﬁed proteins was practically
coincident with that expected from the cDNA sequence (Table 2),
indicating the purity of the sample. The most signiﬁcant difference
Fig. 1. SDS-PAGE of preS-his and deletionmutant puriﬁcation steps. (A) The puriﬁcation steps of preS-his are shown as an example: (1) proteinmarkers; (2) noninduced cells; (3) cells induced
with IPTG for 4 h; (4) pellet from cell lysate; (5) supernatant from cell lysate; (6) protein nonretained in the Ni-NTA column. (B) Protein eluted from the column with 10 mMMOPS pH 8.0,
200 mM imidazole. (1) Protein markers; (2) preS-his; (3) preSΔ1–40; (4) preSΔ20–60; (5) preSΔ40–80; (6) preSΔ60–100; (7) preSΔ80–120. The gel was stained with Coomassie blue.
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onine residues. In all cases, except for the mutant preSΔ1–40, after acid
hydrolysis the methionine content was one residue lower than expect-
ed. It is likely that the amino-terminalmethionine had been removed by
the action of the E. colimethionyl amino peptidase except for the mu-
tant preSΔ1–40 where the peptidase seems not to be able to hydrolyze
the corresponding Met-Trp peptide bond [32].Table 2
Amino acid composition of preS-his, preSΔ1–40, preSΔ20–60, preSΔ40–80, preSΔ60–100 and
preSΔ80–120.
aaa preS-his preSΔ1–40 preSΔ20–60 preSΔ40–80 preSΔ60–100 preSΔ80–120
Asx 21 (21) 10 (10) 12 (12) 18 (18) 19 (19) 18 (18)
Thr 12–13 (14) 10 (11) 10 (11) 11 (12) 10 (11) 7 (8)
Ser 11–13 (14) 9–11 (12) 11–13 (14) 11–13 (14) 8 (10) 8 (10)
Glx 11 (11) 9 (9) 11 (11) 8 (8) 6 (6) 6 (6)
Pro 23 (23) 18 (18) 17 (17) 18 (18) 14 (14) 15 (15)
Gly 16 (16) 14 (14) 12 (12) 8 (8) 11 (11) 15 (15)
Ala 13 (13) 10 (10) 7 (7) 8 (8) 10 (10) 11 (11)
Val 4 (4) 4 (4) 3 (3) 3 (3) 4 (4) 4 (4)
Met 1 (2) 2 (2) 1 (2) 1 (2) 1 (2) 0 (1)3.2. Spectroscopic characterization
The preS domain (subtype ayw) has four tryptophan residues (W32,
W41, W66 and W111) and one tyrosine (Y129). Therefore, all deletion
mutants will have the tyrosine residue, while the tryptophan content
will depend on the deleted sequence, being this number between 2
and 3. Fig. 2 shows the ﬂuorescence emission spectra of preS-his and
the different mutant proteins at pH 7.0 which are very similar to those
obtained at pH 5.0. The ﬂuorescence emission maximum is centered at
344 nm, regardless of the excitation wavelength, which indicates that
the tryptophan residues are found in a relatively polar environment.
The contribution of the tyrosine residue to the ﬂuorescence emission is
very small, negligible in some cases. Thismay reﬂect the lower absorptiv-
ity and quantum yield of Tyr compared to Trp although it could also be
due to a process of resonance energy transfer from Tyr to the nearby
Trp residues or to ﬂuorescence quenching of its neighboring residues in
the three dimensional structure of the protein. Nevertheless, the ﬂuores-
cence intensity at themaximum reﬂects the lower tryptophan content of
mutants preSΔ20–60 and preSΔ40–80.
The far-UV CD spectra of preS-his at pH 7.0 and 5.0 are depicted in
Fig. 3A. The shape of the spectra, with a minimum at 200 nm and a
shoulder at 220 nm, is indicative of a protein with a high percentage
of non-ordered structure. Fig. 3B shows the spectra of the mutant
proteins at pH 7.0 that are very similar to those recorded at pH 5.0 in
all cases. The assignment of the secondary structure elements according
to the algorithm CCA [28] is presented in Table 3. Regardless of pH,
the major repetitive ordered secondary structure component is β-sheet
(9 to 21%, depending of the mutant protein) and, approximately, a
third of the amino acids are in β-turn. It should be noted that 48–59%Table 1
Molecular mass and isoelectric point values of preS-his, preSΔ1–40, preSΔ20–60, preSΔ40–80,
preSΔ60–100 and preSΔ80–120.
preS-his preSΔ1–40 preSΔ20–60 preSΔ40–80 preSΔ60–100 preSΔ80–120
Mr (Da) 18,055 13,843 13,760 14,030 13,984 13,594
pI 8.40 11.34 10.57 8.48 6.78 6.41of the protein has an aperiodic secondary structure and that helical
structure is not present.
3.3. Interaction with phospholipids
The interaction of native and mutant preS domains with phospho-
lipids was studied using two approaches. Firstly, the proteins were la-
beled with NBD-F. Fluorescent labeling of mutant proteins other than
preSΔ1–40 resulted in a precipitated sample. Hence, the labeled proteins
were denatured with 6 M urea, and then the denaturant agent was re-
moved by exhaustive dialysis against 10 mMMOPS pH 5.0 or 7.0. The
far-UV CD spectra of NBD-labeled preS polypeptides were coincident
with those of the unlabeled ones. The extent of labeling was calculated
from the absorbance spectrum. It was found that all the proteins were
labeled approximately in a 1:1 (NBD:protein) ratio. Considering that
the reaction was carried out at pH 6.8, it is expected that the α-amino
group, and not the Lys side chain, be the main labeling target [33].
It has been previously shown that the interaction of NBD-preS-his
protein with neutral phospholipid vesicles is very weak and the binding
constant cannot be determined from this type of experiment [23]. Thus,
PG vesicleswere used to compare the interaction of themutant proteins
with phospholipids. In the absence of phospholipid vesicles, the
emission maximum of NBD-labeled proteins was centered at 546 nm,
a value similar to that described for other NBD derivatives [29]. UponIle 3 (3) 3 (3) 3 (3) 2 (2) 2 (2) 3 (3)
Leu 15 (15) 12 (12) 14 (14) 10 (10) 10 (10) 12 (12)
Tyr 1 (1) 1 (1) 1 (1) 1 (1) 1 (1) 1 (1)
Phe 9 (9) 5 (5) 5 (5) 7 (7) 9 (9) 8 (8)
His 10 (4 + 6) 9 (3 + 6) 9 (3 + 6) 9 (3 + 6) 10 (4 + 6) 8 (2 + 6)
Lys 2 (2) 1 (1) 0 (0) 1 (1) 2 (2) 2 (2)
Arg 7 (7) 6 (6) 6 (6) 7 (7) 5 (5) 4 (4)
Trp N.D.b (4) N.D. (3) N.D. (2) N.D. (2) N.D. (3) N.D. (3)
a The values in parentheses correspond to the theoretical composition determined from
the cDNA sequence.
b N.D. (not determined).
Fig. 2. Fluorescence emission spectra of preS-his (A), preSΔ1–40 (B), preSΔ20–60 (C), preSΔ40–80 (D), preSΔ60–100 (E) and preSΔ80–120 (F) at pH 7.0. The spectrawere obtained upon excitation
at 275 nm (—) and 295 nm (- -). The contribution of tyrosine residues to the emission spectra of the protein (· · · · ·) was calculated as described in the Materials and methods section.
Protein concentration was 0.07 mg/mL. The buffer used was 10 mMMOPS pH 7.0. The results shown are representative of those obtained for three different experiments.
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increased considerably and the emission maximum was shifted to
522–528 nm (Fig. 4), indicating that the ﬂuorescent probe has been
relocated to a more hydrophobic environment. At pH 7.0, the emission
maximum shifted to 532 nm and the increase in ﬂuorescence intensity
was considerably lower (data not shown). From the ﬂuorescence inten-
sity values observed at pH 5.0 the binding isotherms were plotted
(Fig. 5). In the case of the wild-type protein and mutants preSΔ1–40
and preSΔ60–100 two different slopes were observed (Fig. 5A, B, E). This
behavior has been associated with protein aggregation upon binding
to the membrane and the formation of large pores in the vesicles [34].
However, the mutants preSΔ40–80 and preSΔ80–120 only have one slope
in the binding isotherms (Fig. 5D, F) and preSΔ20–60 mutant presented
a very small difference between the two slopes (Fig. 5C). The partition
coefﬁcients, reﬂecting the binding constants, were calculated as theFig. 3. Circular dichroism spectra of preS-his andmutant proteins. (A) preS-his at pH 5.0 (——) a
preSΔ60–100 (▲) and preSΔ80–120 (Δ). Protein concentration was 5 μM and cell path length 0.1 c
representative of those obtained for three different experiments.initial slopes of these binding isotherms (Table 4). In the presence of
acidic phospholipids and at pH 5.0, a value between 1.4 and
2.9 × 104 M−1 was obtained for all recombinants proteins.
Secondly, circular dichroism was used to ascertain the structural
changes which occur in the proteins as the result of their interaction
with phospholipid vesicles. The spectra obtained with both preS-his
and the different mutants in the presence of PG vesicles are shown in
Fig. 6. At pH 5.0 the behavior was very similar for all proteins. Thus,
low concentrations of phospholipid (protein:lipid molar ratio of 1:5)
produced an increase in ellipticity values, which could be due to aggre-
gation of the proteins on the surface of the bilayer resulting in a lower
effective protein concentration. This effect is more pronounced in the
case of preSΔ60–100 and preSΔ80–120 (Fig. 6, pH 5.0, E–F). Since these
two mutants have the lowest isoelectric point of all the recombinant
proteins, they would have a lower positive charge that would enablend 7.0 (- - -). (B)Mutants proteins at pH 7.0, preSΔ1–40 (ο), preSΔ20–60 (■), preSΔ40–80 (□),
m. The buffer employed was 10 mMMOPS at the appropriate pH. The results shown are
Table 3
Secondary structure of preS-his and mutant proteins calculated from the CD spectra ac-
cording to the CCA method [28].
Protein Secondary structure (%)
α-Helix β-Sheet β-Turn Aperiodic
pH 7.0 pH5.0 pH 7.0 pH5.0 pH 7.0 pH5.0 pH 7.0 pH5.0
preS-his 0 0 18 15 30 32 52 53
preSΔ1–40 0 0 12 12 34 36 54 52
preSΔ20–60 0 0 18 9 32 36 50 55
preSΔ40–80 0 0 18 11 30 30 52 59
preSΔ60–100 2 0 21 15 29 26 48 59
preSΔ80–120 3 0 17 17 28 26 52 57
900 C.L. Delgado et al. / Biochimica et Biophysica Acta 1848 (2015) 895–906them to interact and form aggregates in a higher proportion. When the
phospholipid concentration was increased, protein:lipid molar ratio of
1:20, a shift from 200 nm to 210 nm and the appearance of a shoulder
at 225 nmwere observed, indicating a conformational change to a sec-
ondary structure with a higher content in helical structures. When the
concentration of phospholipid was increased to a protein:lipid molar
ratio of 1:50, the helical conformation was maintained resulting in a
spectrum similar in shape to that observed at a 1:20 molar ratio but
with lower ellipticity values, probably due to the presence of a higher
proportion of protein in monomeric form. At pH 7.0, the differences
between the spectra obtained at 1:20 and 1:50 practically disappeared.
As it can be seen in Table 5, where the percentages of the different sec-
ondary elements at a protein:lipid molar ratio of 1:50 are shown, al-
though the percentage of non-ordered structure was still high, the
percentages of α-helix (14–23%) and β-sheet (16–40%) increased con-
siderably at the expense of β-turn. At pH 7.0, and except for the
preSΔ1–40 mutant, an increase in α-helix concomitant with a decrease
in the percentage of extended structure in all cases was observed.
3.4. Vesicle destabilization
The HBV preS domains have been shown to have membrane desta-
bilization properties [23], including the ability to cause vesicle aggrega-
tion, lipid mixing and release of aqueous contents. The capability of the
deletion mutants to retain these properties was also examined. VesicleFig. 4. Fluorescence spectra of NBD-preS-his (A), NBD-preSΔ1–40 (B), NBD-preSΔ20–60 (C), NBD-p
an excitationwavelength of 467 nm. The protein concentration usedwas 0.15–0.20 μM. The spe
ratio of 5000:1 after incubation of the protein with PG vesicles in medium buffer at pH 5.0
experiments.aggregationwas followed bymeasuring the variation of the optical den-
sity at 360 nm (ΔOD360) after incubation of PG vesicles at a concentra-
tion of 60 μM with different concentrations of protein at 37 °C for 1 h.
At pH 7.0, the highest increase in optical density occurs with the wild
type protein and preSΔ20–60, whereas preSΔ1–40, preSΔ40–80 and
preSΔ60–100 produced a lower increase and preSΔ80–120 was not able to
induce aggregation (Fig. 7A). However, at pH 5.0 the ΔOD360 increased
in a concentration dependent manner reaching a maximum at 5.5 μM
in all cases (Fig. 7A).
Lipidmixing of phospholipid vesicles was followed by the resonance
energy transfer (RET) assay between the ﬂuorescence probes NBD-PE
and Rh-PE incorporated into a lipidmatrix inwhichmixing of phospho-
lipids from labeled and unlabeled liposomes resulted in a decrease in
energy transfer [30]. Native preS as well as themutants were able to in-
duce lipidmixing at pH 7.0, although the decrease in energy transfer in-
duced by preSΔ100–120 was higher at lower concentrations of protein
(Fig. 7B). The % RET decreased from 65% in the absence of protein, up
to 6.5% for a ﬁnal protein concentration of 8 μM. These values corre-
spond to a 10-fold dilution in the acceptor surface density, indicating
that the complete fusion of vesicles has been induced, since the mere
aggregation would not account for this decrease in energy transfer
[35]. The same ﬁnal effect was observed for preS-his and preSΔ40–80
and preSΔ60–100 mutants, reaching in all cases the complete fusion of
the vesicles. In the case of preSΔ1–40 and preSΔ20–60, the % RET only de-
creases to 29 and 15% respectively (Fig. 7B), probably because vesicle
aggregation prevailed over fusion. At pH 5.0 there were nomajor differ-
ences between proteins, leading to a decrease in the % RET to 10% in all
cases, which implies the complete fusion of vesicles (Fig. 7B).
The increase in permeability induced by the addition of preS domain
and mutant proteins has been studied according to the assay described
by Ellens [31]. As described above for aggregation and lipid mixing, the
release of aqueous contents is also a protein concentration-dependent
process although themaximumeffect at pH 7.0was reached at a protein
concentration (0.25–2.0 μM) much lower than that needed to achieve
themaximum effect in the other assays (5–8 μM) (Fig. 7C). For themu-
tant preSΔ1–40, the maximum effect was reached at the lowest protein
concentration (0.2 μM), whereas preSΔ40–80 and preSΔ80–120 required a
concentration 10 times higher, 2 μM (Fig. 7C). The maximum ﬂuores-
cence value reached (85–99%) was similar to that described for otherreSΔ40–80 (D), NBD-preSΔ60–100 (E) and NBD-preSΔ80–120 (F). Spectraweremeasuredwith
ctra of the proteins in the absence (- - -) and presence (—) of lipids at a lipid:proteinmolar
are shown. The results shown are representative of those obtained for three different
Fig. 5. Binding isotherm of NBD-preS-his (A), NBD-preSΔ1–40 (B), NBD-preSΔ20–60 (C), NBD-preSΔ40–80 (D), NBD-preSΔ60–100 (E) and NBD-preSΔ80–120 (F) to PG vesicles at pH 5.0. Values of
Xb* and Cf are calculated from the increments in ﬂuorescence intensity at 530 nmas described in theMaterials andmethods section. Insets represent the initial slope of the corresponding
binding isotherm used to calculate the partition coefﬁcients. The results shown are representative of those obtained for three different experiments.
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X-100 (100%). At pH 5.0 the behavior of all proteinswas nearly identical
and in all cases a lower protein concentration is needed to attain the
same effect observed at pH 7.0 (Fig. 7C).
4. Discussion
We have previously suggested that different regions of the surface
proteins of HBVmay be involved in the fusion of viral and cellular mem-
branes [23]. Speciﬁcally, the N-terminal portion of the S protein and the
preS domains were proposed to contribute at the fusion process either
simultaneously or at different stages. To gain information on the location
of the region(s) responsible for the destabilizing properties of preS do-
main we have cloned and puriﬁed the preS domain (subtype ayw) and
ﬁve deletion mutants where a region of 40 amino acids of the preS1 re-
gion has been consecutively removed along the sequence of preS
(preSΔ1–40, preSΔ20–60, preSΔ40–80, preSΔ60–100 and preSΔ80–120). About
15 mg of wild-type protein and 3–6 mg of highly pure mutated protein
per liter of culture medium have been obtained.
The spectroscopic characterization of preS domain and deletionmu-
tants was carried out by means of circular dichroism and ﬂuorescence
spectroscopy. PreS domain possesses a high percentage of nonorderedTable 4
Fluorescence emission maxima and partition coefﬁcients of the interaction of NBD-preS-
his, NBD-preSΔ1–40, NBD-preSΔ20–60, NBD-preSΔ40–80, NBD-preSΔ60–100 and NBD-preSΔ80–
120 with PG vesicles.
Protein pH PG emission maxima K (M−1) × 10−4
NBD-preS-his 7.0 532 0.3 ± 0.1
5.0 522 2.9 ± 0.7
NBD-preSΔ1–40 5.0 526 1.8 ± 0.5
NBD-preSΔ20–60 5.0 528 1.7 ± 0.2
NBD-preSΔ40–80 5.0 523 2.4 ± 0.5
NBD-preSΔ60–100 5.0 528 2.8 ± 0.7
NBD-preSΔ80–120 5.0 528 1.4 ± 0.8structure with the different secondary structure elements arranged in
an open conformation [26,36,37]. Deconvolution of far-UV circular
dichroism spectra shows that the secondary structure of the mutant
proteins does not vary signiﬁcantly with respect to that of the native
protein. 48–59% of the residues are in non-regular structure, while
β-sheet is the major ordered repetitive structure (9–21%).
PreS domains have the ability to interact with phospholipid vesicles,
as indicated by the changes that the ﬂuorescence spectrum of
NBD-labeled protein undergoes when challenged by phospholipids
[23]. Since the highest effect was observed with acidic phospholipids
at pH 5.0, the experiments with the truncated forms were carried out
under these conditions. In the presence of PG vesicles at pH 5.0, theﬂuo-
rescence emission maximum of NBD shifts from 546 to 526–528 nm in
all cases. This change reﬂects a relocation of NBD into amore hydropho-
bic environment and is comparable to that obtained for peptides which
are known to insert deeply into the bilayer [29,34,38,39]. Furthermore,
binding isotherms, derived from the increments in ﬂuorescence intensi-
ties, provide information about the way in which the interaction occurs
[40,41]. The two slopes which are observed in all cases, except preSΔ40–
80 and preSΔ80–120, are indicative of a high tendency to interact with the
lipid bilayer and to form aggregates and pores [34]. The shape of the
binding isotherm obtained for preSΔ40–80 and preSΔ80–120, with a single
slope, could indicate that, at the concentration range studied, the inter-
action of these mutants occurs in a monomeric form originating small
pores. Therefore, it seems that some of the amino acids deleted in
these two mutants are necessary for the oligomerization to take place.
The partition coefﬁcients, which reﬂect the binding constant, were
calculated from the initial slope of the binding isotherm, resulting in
all cases a value of the order of 104 M−1, similar to that previously
obtained for preS (subtype adw) [23] and duck hepatitis B virus preS
domains [24]. They are also very similar to those described in the case
of peptides that strongly interact with the bilayer, as is the case of
peptides corresponding to the HA protein of inﬂuenza virus [42], the
internal peptide of Sendai virus [39] and peptides able to form pores
therein [29,38].
Fig. 6. CD spectra of preS-his (A) and preSΔ1–40 (B), preSΔ20–60 (C), preSΔ40–80 (D), preSΔ60–100 (E) and preSΔ80–120 (F) in the presence of PG. The spectraweremeasured after incubation of
the protein in 10mMMOPS pH 5.0 or 7.0 with different concentrations of the phospholipid for 1 h at 37 °C. The protein concentration was 5 μM. Protein in solution (●) and protein in the
presence of PG at a protein:lipid molar ratio of 1:5 (ο), 1:20 (▲) and 1:50 (Δ). The results shown are representative of those obtained for three different experiments.
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the preS domains and mutant proteins. CD spectra obtained in the
presence of acidic phospholipid vesicles show that at low concentra-
tions of phospholipid the value of the molar ellipticity increases in all
cases, more at pH 7.0 and at pH 5.0 for preSΔ60–100 and preSΔ80–120.
Under these conditions, and given the low lipid concentration, an in-
crease in the surface density of proteins in the bilayer could favor its ag-
gregation and hence, a higher local concentration of chromophores
which could promote a decrease in absorption [43,44]. This aggregation
effect is transient because when the concentration of phospholipid in-
creases a reduction in the ellipticity values is noticed. In this regard, it
was found that the carboxy- and amino-terminal heptad region of the
fusion protein of Sendai virus form complexes in solution [45] which
then dissociate into monomers when they bind to the membranes
[46]. A similar effect has been described for HIV [47]. As a result of the
interaction with acidic phospholipids, from a protein:lipid molar ratio
of 1:20 and both at pH 7.0 and 5.0, there is a conformational change of
the protein that resulted in an increase of the percentage of helicalTable 5
Secondary structure of preS-his andmutant proteins in thepresence of PG at a protein/lipid
molar ratio of 1:50 calculated from the CD spectra according to the CCA method [28].
Protein Secondary structure (%)
α-Helix β-Sheet β-Turn Aperiodic
pH 7.0 pH 5.0 pH 7.0 pH 5.0 pH 7.0 pH 5.0 pH 7.0 pH 5.0
preS-his 16 17 6 40 30 8 48 35
preSΔ1–40 17 22 35 32 16 10 32 36
preSΔ20–60 24 23 0 26 27 10 49 41
preSΔ40–80 22 22 0 25 28 8 50 45
preSΔ60–100 18 22 5 30 23 7 54 41
preSΔ80–120 19 14 2 16 25 22 54 48content, that is very similar in all cases, except for preSΔ80–120 mutant
at pH 7.0, which retain a high content of non-ordered structures. As in-
dicated above, the results obtained with the domains labeled with NBD
point to the insertion of the amino-terminal end of the protein into the
bilayer. In this sense, myristoylation of the Gly2 residue of the preS do-
main [3] would help this region to insert. Thus, it seems reasonable to
think that the conformational transition to a helical structure occurs in
this area, remaining the rest of the protein at the polar surface, main-
taining its original structure. As it has been reported in other fusogenic
viral proteins, such as the hemagglutinin inﬂuenza virus [48,49] or the
vesicular stomatitis virus [50], preS domains not only interact with but
also are able to destabilize model membrane systems. Both native and
mutant proteins have destabilizing properties (aggregation, lipid
mixing and release of aqueous contents) in a pH-dependent manner,
with the effects observed at pH5.0 higher than those obtained at neutral
pH, especially at low protein concentration. Aggregation results at
pH 7.0 are those which provide greater differences between the recom-
binant proteins. According to these results, the region 20–60 is
completely dispensable since the mutant preSΔ20–60 gives comparable
results to those obtained with full length preS domain. Similarly, the
1–40 region seems not to have any involvement in the interactions
that promote vesicle aggregation. However, any of the other areas that
are missing in the other three mutants would be required for the estab-
lishment of such interactions, especially the regions 40–80 and 80–120.
The differences could be explained on the basis of the net charge of the
protein at pH 7.0. The mutants preSΔ60–100 and preSΔ80–120 that have a
similar isoelectric point, 6.78 and 6.41 respectively (Table 1) would
have the same behavior. However, preSΔ80–120 is not able to induce ag-
gregation, while preSΔ60–100 induces vesicle aggregation to the same
level than the mutant preSΔ1–40, which is the one with the highest pos-
itive charge at neutral pH (pI 11.34). It is therefore clear that ionic inter-
actions are important in determining the aggregation but there must be
Fig. 7.Aggregation (A), lipidmixing (B) and leakage (C) of PG vesicles induced at pH7.0 and 5.0 bypreS-his (●), preSΔ1–40 (ο), preSΔ20–60 (■), preSΔ40–80 (□), preSΔ60–100 (▲) and preSΔ80–
120 (Δ). Theﬁnal phospholipid concentrationwas 60 μM(A) and 0.14mM(B and C). The results shown are representative of those obtained for at least three different experiments. (A) The
increase in optical density at 360 nm (ΔOD360) was measured after incubation of the vesicles with the proteins at different concentrations. Values of control samples containing only PG
liposomeswere subtracted. (B) Increasing concentrations of thedifferent proteinswere added to a 1:9mixture of labeled (NBD-PE 1% and Rh-PE 1%) andunlabeled PGvesicles hydrated in
medium buffer. (C) Increasing concentrations of the different proteins were added to PG vesicles loaded with ANTS and DPX. The %Fmax was calculated with respect the value obtained
upon addition of 0.5% Triton X-100. F.
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the results of the interaction studies with NBD-labeled proteins,
preSΔ40–80 and preSΔ80–120 are themutants that interactwith lipid bilay-
ers in a monomeric way. The rest of mutants and the wild type protein
induce aggregates that can give rise to an extensive network of vesicles,
interacting among themselves, that would account for the increase in
optical density at 360 nm. The fact that preSΔ60–100 can form oligomers
and induce aggregation, like the rest ofmutants, is indicative that the re-
gions responsible for this effect are located between amino acids 40–60
and 100–120.
The inability of mutant preSΔ40–80 and preSΔ80–120 to form aggre-
gates upon interaction with phospholipids could explain their reduced
ability to induce release of aqueous contents, since the absence of such
complexes has been also related to the formation of smaller pores on
the membrane [29]. On the other hand, interaction in a monomeric
way may also facilitate the diffusion of NBD-PE and Rh-PE molecules
in the fused vesicles, allowing the preSΔ80–120 mutant to induce lipid
mixing more efﬁciently. In contrast, preSΔ1–40 and preSΔ20–60, with a
greater capacity to form protein aggregates on the bilayer, are those
that produce the greatest vesicle aggregation and release of aqueous
contents. In this regard, it has been postulated that oligomerization is
necessary for the oblique insertion of fusogenic peptides in the mem-
brane, a condition which strongly promotes fusion [51–53].
Special attention must be paid to the results obtained with mutants
preSΔ1–40 and preSΔ20–60. These proteins have a greater ability to desta-
bilize lipid vesicles, both at pH 7.0 and pH 5.0 and at lower protein con-
centration, than the wild type protein. This could indicate that the ﬁrst
60 amino acids are not required to initiate the fusion process. This re-
gion has been related to the interaction with the receptor and to the
species speciﬁcity [3,13]. In addition, the region between amino acids
47 and 67 is the most hydrophobic of the preS domain with ahydrophobicity index of 0.7 (Fig. 8), and could be responsible for the in-
sertion of the preS domain in lipid bilayer. Indeed, it possesses the char-
acteristic of a transmembrane helix and also the Gly-X-Phe sequence
characteristic of fusogenic peptides, present in the inﬂuenza virus and
in a reversed form at the amino-terminal of the fusogenic peptide of
paramyxovirus, in the center of retrovirus and S domain of HBV [54].
It is also a highly conserved domain among the different HBV subtypes
(Fig. 9A) and has sequence homologywith fusogenic peptides of viruses
such as HIV (Fig. 9B). However, as noted above, this area does not ap-
pear to be necessary in the mutants to destabilize lipid vesicles.
All the differences between the mutant proteins disappear at acidic
pH and high protein concentration. This could be related to the higher
positive charge of all the mutants at lower pH. Anyway, it is clear that
all of the mutants, to a greater or lesser extent, may interact with acidic
phospholipid and display all the properties assigned to fusogenic pro-
teins. These data would indicate that there is no a speciﬁc region of
the protein responsible for the fusion of viral and cellular membranes.
Like other viruses, such as paramyxoviruses, where there are no se-
quencehomologies between them [55,56], it is the tridimensional struc-
ture of the fusogenic peptides what determines the ability to destabilize
vesicles and not the amino acid sequence [57,58]. In this regard, the CD
spectra indicate that both the full-length protein and themutants have a
similar secondary structure.Moreover, the hydrophobicity proﬁles indi-
cate that all the proteins share a similar distribution of polar and nonpo-
lar amino acids (Fig. 8). Since all proteins used in this study share the
carboxyl-terminal region, which corresponds to the preS2 domain,
this area could be responsible for the ionic interaction with the polar
head of the phospholipids. Then, the preS1 domain could insert into
the bilayer causing its destabilization due to the fact that there is a par-
ticular three dimensional structure and/or a distribution of speciﬁc
amino acids.
Fig. 8. Hydrophobicity proﬁle of preS-his (A) and mutants preSΔ1–40 (B), preSΔ20–60 (C), preSΔ40–80 (D), preSΔ60–100 (E) and preSΔ80–120 (F). The hydrophobicity index was calculated ac-
cording to the scale proposed by Eisenberg [60].
904 C.L. Delgado et al. / Biochimica et Biophysica Acta 1848 (2015) 895–906Wehave previously proposed that both the N-terminal region of the
S protein aswell as the preS domainsmay be involved in the initial steps
of viral infection [23]. Thus, antibodies elicited against both regionsmayA
ayw ---------- -MGQNLSTSN PLGF
adw MGGWSSKPRK GMGTNLSVPN PLGF
ayr MGGWSSKPRQ GMGTNLSVPN PLGF
adr MGGWSSKPRQ GMGTNLSVPN PLGF
ayw TWPDANKVGA GAFGLGFTPP HGGL
adw HWPAANQVGV GAFGPGFTPP HGGV
ayr HWPEANQVGA GAFGPGFTPP HGGL
adr HWPDGIKVGA GDFGPGFTPP HGGL
ayw SGRQPTPLSP PLRNTHPQAM QWNS
adw SGRQPTPLSP PLRNTHPQAM QWNS
ayr SGRQPTPLSP PLRNTHPQAM QWNS
adr SGRQPTPLSP PLRNTHPQAM QWNS
ayw VNPVLTTASP LSSIFSRIGD PALN
adw VNPAPNIASH ISSISARTGD PVTN
ayr VNPVPTTASP ISSIFSRTGD PAPN
adr VNPVPTTASP ISSIFSRTGD PAPN
B
HBV V G A G A F G . L G F T P 
HIV-1 V G I G A L . F L G F L G 
HIV-2 G V F V L G F L G F L A 
SIV G V F V L G F L G F L A 
Fig. 9.Amino acid sequence of thepreS domains of different HBV subtypes (A). Comparison of po
GXF found in other fusogenic peptides is underlined. Sequence identities are shown in black bplay an important role in controlling the infection. Although this study
shows that the ﬁrst 60 amino acids of preS do not seem to be involved
in the interaction and destabilization of lipid bilayers, and since it hasFPDHQL DPAFRANTAN PDWDFNPNKD 39
FPDHQL DPAFGANSNN PDWDFNPIKD 50
FPDHQL DPAFGANSNN PDWDFNPNKD 50
FPDHQL DPAFGANSNN PDWDFNPNKD 50
LGWSPQ AQGILQTLPA NPPPASTNRQ 89
LGWSPQ AQGILTTVST IPPPASTNRQ 100
LGWSPQ AQGILTTLPA APPPASTNRQ 100
LGWSPQ AQGILTTVPA APPPASTNRQ 100
TTFHQT LQDPRVRGLY FPAGGSSSGT 139
TAFHQT LQDPRVRGLY FPAGGSSSGT 150
TTFHQT LLDPRVRGLY FPAGGSSSGT 150





P H G G L L G W
A A G S T M G A
T A G S A V G A
T A G S A I G A
sitions 47–66 of preS (ayw)with different retrovirus fusogenic peptides (B). The sequence
oxes.
905C.L. Delgado et al. / Biochimica et Biophysica Acta 1848 (2015) 895–906been shown that this region is important for the infectivity [3] the use of
full-length preS domains as part of a vaccine against HBV infection
seems appropriate. In fact, it has been reported an increase in antibody
response to a vaccine containing both preS1 and preS2 even in a popu-
lation that include low responders to the conventional vaccine [59].
Also, there is a phase II clinical trials in chronic HBV-infected patients
with a vaccine including preS-derived peptides [2].Acknowledgements
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